A detailed history of Texas Permanent School Fund transactions in Vericel Corp stock. As of the latest transaction made, Texas Permanent School Fund holds 41,768 shares of VCEL stock, worth $1.95 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
41,768
Previous 41,227 1.31%
Holding current value
$1.95 Million
Previous $1.47 Million 47.96%
% of portfolio
0.02%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$32.52 - $52.33 $17,593 - $28,310
541 Added 1.31%
41,768 $2.17 Million
Q4 2023

Feb 08, 2024

BUY
$30.85 - $37.09 $23,631 - $28,410
766 Added 1.89%
41,227 $1.47 Million
Q3 2023

Nov 09, 2023

SELL
$31.69 - $39.25 $44,968 - $55,695
-1,419 Reduced 3.39%
40,461 $1.36 Million
Q2 2023

Aug 07, 2023

SELL
$29.0 - $38.37 $13,630 - $18,033
-470 Reduced 1.11%
41,880 $1.57 Million
Q1 2023

May 01, 2023

BUY
$23.85 - $31.34 $252,881 - $332,298
10,603 Added 33.4%
42,350 $1.24 Million
Q4 2022

Feb 07, 2023

SELL
$17.65 - $27.37 $38,582 - $59,830
-2,186 Reduced 6.44%
31,747 $836,000
Q3 2022

Oct 25, 2022

SELL
$22.62 - $32.54 $2,804 - $4,034
-124 Reduced 0.36%
33,933 $787,000
Q2 2022

Aug 08, 2022

BUY
$22.88 - $39.45 $19,836 - $34,203
867 Added 2.61%
34,057 $858,000
Q1 2022

May 06, 2022

SELL
$31.69 - $43.29 $17,809 - $24,328
-562 Reduced 1.67%
33,190 $1.27 Million
Q4 2021

Feb 08, 2022

SELL
$35.2 - $52.6 $26,118 - $39,029
-742 Reduced 2.15%
33,752 $1.33 Million
Q3 2021

Oct 28, 2021

SELL
$46.35 - $59.75 $2,410 - $3,107
-52 Reduced 0.15%
34,494 $1.68 Million
Q2 2021

Jul 27, 2021

BUY
$47.2 - $67.81 $10,053 - $14,443
213 Added 0.62%
34,546 $1.81 Million
Q1 2021

May 03, 2021

BUY
$30.93 - $59.48 $1.06 Million - $2.04 Million
34,333 New
34,333 $1.91 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.2B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.